Fonte: Brazilian Journal of Medical and Biological Research. Unidade: FMRP
Assuntos: OSTEOPOROSE, BIOMECÂNICA, MODELOS ANIMAIS, FÁRMACOS
ABNT
PEREIRA, F. A. et al. Pamidronate for the treatment of osteoporosis secondary to chronic cholestatic liver disease in Wistar rats. Brazilian Journal of Medical and Biological Research, v. 45, n. 12, p. 1255-1261, 2012Tradução . . Disponível em: https://doi.org/10.1590/S0100-879X2012007500143. Acesso em: 21 maio 2024.APA
Pereira, F. A., Mattar, R., Facincani, I., Defino, H. L. A., Ramalho, L. N. Z., Jorgetti, V., et al. (2012). Pamidronate for the treatment of osteoporosis secondary to chronic cholestatic liver disease in Wistar rats. Brazilian Journal of Medical and Biological Research, 45( 12), 1255-1261. doi:10.1590/S0100-879X2012007500143NLM
Pereira FA, Mattar R, Facincani I, Defino HLA, Ramalho LNZ, Jorgetti V, Volpon JB, Paula FJA de. Pamidronate for the treatment of osteoporosis secondary to chronic cholestatic liver disease in Wistar rats [Internet]. Brazilian Journal of Medical and Biological Research. 2012 ; 45( 12): 1255-1261.[citado 2024 maio 21 ] Available from: https://doi.org/10.1590/S0100-879X2012007500143Vancouver
Pereira FA, Mattar R, Facincani I, Defino HLA, Ramalho LNZ, Jorgetti V, Volpon JB, Paula FJA de. Pamidronate for the treatment of osteoporosis secondary to chronic cholestatic liver disease in Wistar rats [Internet]. Brazilian Journal of Medical and Biological Research. 2012 ; 45( 12): 1255-1261.[citado 2024 maio 21 ] Available from: https://doi.org/10.1590/S0100-879X2012007500143